The announcement was made after market hours yesterday, 14 May 2020.

The United States Food and Drug Administration (USFDA) conducted the inspection of the active pharmaceutical ingredients (APIs) facility from 17th to 21st February 2020. The EIR was received on 13 May 2020.

Unichem Laboratories is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in several markets across the world.